Commercially available enzyme-linked immunosorbent assays (ELISA) were used for determination of total GLP-1 (736 and 936) (ALPCO, Salem, NH), GLP-2 (133 and 333) (Merck Millipore, Burlington, MA) and DPP4 (R&D Systems, Minneapolis, MN) plasma concentrations and were carried out according to the manufacturers instructions
A recent study raises questions about whether GLP-1 drugs like Ozempic and Mounjaro actually increase thyroid cancer risks, indicating that previously suggested associations may be the result of more intensive screening, rather than side effects the drugs have on the body
So far, I have yet to come across a clear side effect but will keep an eye out for it
Background Autoimmune pancreatitis (AIP) is an increasingly recognised entity encompassing at least two types of pancreatitis.1 Type 1 AIP represents the most common manifestation of IgG4-related disease, a relapsing-remitting systemic fibro-inflammatory disorder characterised by increased production of IgG4 antibodies in affected tissues.1 Type 2 AIP is associated with inflammatory bowel diseases (namely Crohns disease and ulcerative colitis) and typically recurs less frequently than type 1 AIP.2 Although the pathogenesis of AIP is far from being solved, type 1 AIP likely involves the interplay between auto-reactive Footnotes Contributors The following authors were responsible for drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms and critical revision for important intellectual content: ML, JM, EA and EDT

Prescription medications are provided only after consultation with a physician to determine if the medication is appropriate for you
Regular Follow-Ups and Monitoring Our providers will schedule regular follow-up visits, particularly during your first year of treatment